VI.E.M.A.
Vision Equipment for Magnetic Activation of Localized Hypertermia
Scheda del progetto
The service involves the design of a radiofrequency system by Ei.En. for Vision S.p.A.. This system will generate an alternating magnetic field to activate Nanoradox nanoparticles, causing a localized and controlled temperature increase, which will induce apoptosis in tumor cells in the Head and Neck region.
Contact:
Andrea Agazzi
The VI.E.M.A. service aims to design a radiofrequency system to activate Vision S.p.A.'s Nanoradox nanoparticles. It will use a power supply, a resonant cell, and software to control temperature during the treatment of Head and Neck tumors. SMART objectives will ensure the specificity, measurability, and relevance of the innovation in oncology treatment. The activities include feasibility analysis, technical solution studies, and the development of integrated software.
The VI.E.M.A. service by Vision S.p.A. stands out for its innovative development of a radiofrequency system to safely and effectively activate Nanoradox nanoparticles in Head and Neck tumors, enabling advanced localized hyperthermia treatment. This system, combined with the VI.S.Y.O. software, surpasses current standards in oncology therapy, ensuring safety and competitiveness in achieving CE marking. The technological challenge lies in designing the antenna and power supply to ensure the effectiveness of the magnetic field at various tissue depths, offering a pioneering solution in the current medical landscape.
The VI.E.M.A. service by Vision will have a significant impact on the company’s economy. Additionally, the acquired know-how will foster ongoing collaboration with the supplier Ei.En., enabling exploration of new applications and engaging stakeholders in the market entry process. The proposed system will greatly simplify healthcare operations, improving treatment effectiveness and contributing to Vision's growth.